Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model

World Journal of Gastroenterology

Volumn 13, Issue 30, 2007, Pages 4131-4135

  Zhu, Jin Shui ^a   Song, Ming Quan ^a   Chen, Guo Qiang ^a   Li , Qin ^a   Sun, Qun ^a   Zhang, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gastric cancer; NM 3; Paclitaxel

Indexed keywords

2 (8 HYDROXY 6 METHOXY 1 OXO 1H 2 BENZOPYRAN 3 YL)PROPIONIC ACID; DNA FRAGMENT; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ELECTROPHORESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MOUSE; NICK END LABELING; NONHUMAN; SCID MOUSE; STOMACH CANCER;

EID: 34548275407     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i30.4131     Document Type: Article

References (20)

1. Nan KJ, Jing Z, Gong L. Expression and altered subeellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 1425-1430
2. Bryja V, Pachernik J, Faldikova L, Krejci P, Pogue R, Nevriva I, Dvorak P, Hampl A. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo. Biochim Biophys Acta 2004; 1691: 105-116
3. Chen J, Xu SY, Deng CS. Efficient generation of human mutant p27 recombinant adenovirus by homologous recombination in bacteria. J Fourth Mil Med Univ 2004; 5: 406-409
4. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22
5. Bryja V, Pachernik J, Faldikova L, Krejci P, Pogue R, Nevriva I, Dvorak P, Hampl A. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo. Biochim Biophys Acta 2004; 1691: 105-116
6. Liu E, Li X, Yan F, Zhao Q, Wu X. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. J Biol Chem 2004; 279: 17283-17288
7. Takeda A, Osaki M, Adachi K, Honjo S, Ito H. Role of the phosphatidylinositol 3′-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas 2004; 28: 353-358
8. Guo W, Shang F, Liu Q, Urim L, West-Mays J, Taylor A. Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation. Invest Ophthalmol Vis Sci 2004; 45: 1194-1201
9. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004; 428: 194-198
10. Kudo Y, Kitajima S, Sato S, Ogawa I, Miyauchi M, Takata T. Transfection of p27(Kip1) threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squarnous cell carcinoma cells. Oncology 2002; 63: 398-404
11. Hurteau JA, Brutkiewicz SA, Wang Q, Allison BM, Goebl MG, Harrington MA. Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth. Gynecol Oncol 2002; 86: 19-23
12. Koguchi K, Nakatsuji Y, Nakayama K, Sakoda S. Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27(Kip1). Glia 2002; 37: 93-104
13. Zhang D, Holmes WF, Wu S, Soprano DR, Soprano KJ. Retinoids and ovarian cancer. J Cell Physiol 2000; 185: 1-20
14. Koh TY, Park SW, Park KH, Lee SG, Seol JG, Lee DW, Lee CT, Heo DS, Kim KH, Sung MW. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines. Head Neck 2003; 25: 44-49
15. Sasaki T, Katayose Y, Suzuki M, Yamamoto K, Shiraso S, Mizuma M, Unno M, Takeuchi H, Lee CT, Matsuno S. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type. Hepatogastroenterology 2004; 51: 68-75
16. Park KH, Seol JY, Kim TY, Yoo CG, Kim YW, Han SK, Shim YS, Lee CT. An adenovirus expressing mutant p27 showed more potent antitumor effects than adenovirus-p27 wild type. Cancer Res 2001; 61: 6163-6169
17. Park KH, Lee J, Yoo CG, Kim YW, Han SK, Shim YS, Kim SK, Wang KC, Cho BK, Lee CT. Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27. J Neurosurg 2004; 101: 505-510
18. Winteringham LN, Kobelke S, Williams JH, Ingley E, Klinken SP. Myeloid Leuken-da Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation. Oncogene 2004; 23: 5105-5109
19. Kumagai H, Masuda T, Ohsono M, Hattori S, Naganawa H, Sawa T, Hamada. M, Ishizuka M, Takeuchi T. Cytogenin, a novel antitumor substance. J Antibiot (Tokyo) 1990; 43: 1505-1507
20. Zhu JS, Shen B, Chen JL, Chen GQ Yu XH, Yu HF, Zhu ZM. Molecular action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro. World J Gastroenterol 2003; 9: 2366-2369